Bank Julius Baer & Co’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-3,028
| Closed | -$18K | – | 600 |
|
2021
Q4 | $18K | Sell |
3,028
-5,805
| -66% | -$34.5K | ﹤0.01% | 746 |
|
2021
Q3 | $78K | Buy |
8,833
+5,040
| +133% | +$44.5K | ﹤0.01% | 644 |
|
2021
Q2 | $30K | Buy |
3,793
+945
| +33% | +$7.47K | ﹤0.01% | 726 |
|
2021
Q1 | $22K | Sell |
2,848
-1,255
| -31% | -$9.7K | ﹤0.01% | 741 |
|
2020
Q4 | $32K | Sell |
4,103
-1,028
| -20% | -$8.02K | ﹤0.01% | 724 |
|
2020
Q3 | $50K | Sell |
5,131
-6,351
| -55% | -$61.9K | ﹤0.01% | 601 |
|
2020
Q2 | $120K | Buy |
11,482
+3,436
| +43% | +$35.9K | ﹤0.01% | 512 |
|
2020
Q1 | $47K | Buy |
+8,046
| New | +$47K | ﹤0.01% | 548 |
|